Connection Between Epigenome, Selective Mutability, Evolution, and Human Disease
Li, Harris et al., PLoS Genetics
Researchers at the Baylor College of Medicine and elsewhere propose a "connection between the epigenome, selective mutability, evolution, and human disease" based on the findings of their study on associations of structural mutability with germline DNA methylation and with non-allelic homologous recombination mediated by low-copy repeats. "Combined evidence from four human sperm methylome maps, human genome evolution, structural polymorphisms in the human population, and previous genomic and disease studies consistently points to a strong association of germline hypomethylation and genomic instability," the Baylor-led team writes.
Bruker's Q4 Revenues Drop 9 Percent; Shares Rise as It Beats Estimates
March 03, 2009
Though the firm's revenues were down year over year for the quarter, its full-year 2008 revenues increased 7 percent. Investors also sent Bruker's shares up in early trade, as the firm handily beat analysts' consensus estimate for EPS.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register quickly here for free access.
New to GenomeWeb? Register quickly here for free access.
Related Stories
- Pittcon 2012 Light on LC-MS Product Releases, But Offers Insights into Vendors' Clinical Plans
March 16, 2012 / ProteoMonitor - Bruker Posts 14 Percent Jump in Q4 Revenues; MALDI Biotyper Could Receive FDA Approval This Year
February 24, 2012 / ProteoMonitor - At JP Morgan, Vendors Tout Strong Mass Spec Releases as Antidotes to Academic/Government Gloom
January 13, 2012 / ProteoMonitor - Big Names Join Clinical Proteomics Push in 2011, Offering Ray of Optimism Amidst Difficult Year
January 6, 2012 / ProteoMonitor - Bruker Q3 Revenues Up 35 Percent; CEO Predicts Funding Shift Toward Proteomics
October 28, 2011 / ProteoMonitor